Status:
TERMINATED
Combined MRI and Optical Imaging to Improved Breast Cancer Diagnosis
Lead Sponsor:
University of California, Irvine
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Breast Cancer
Eligibility:
FEMALE
21-90 years
Phase:
NA
Brief Summary
This study investigates whether adding the optical imaging to magnetic resonance imaging can improve the diagnostic specificity of breast cancer.
Detailed Description
This proposal will investigate the performance of a combined optical-MRI imaging system in diagnosis of breast cancer. A diffuse optical tomography (DOT) imaging system will be integrated with a 3.0 T...
Eligibility Criteria
Inclusion
- A female older than 21 years of age,
- Have suspicious imaging findings suggesting a possibility of breast cancer, or biopsy-proven breast cancer.
Exclusion
- Pregnant,
- Unwilling to give informed consent,
- Have implanted prosthetic heart valves, pacemaker, neuro-stimulation devices, surgical clips (hemostatic clips) or other metallic implants,
- Have engaged in occupations or activities which may cause accidental lodging of ferromagnetic materials, or have imbedded metal fragments from military activities,
- Have received orthodontic work involving ferromagnetic materials,
- Claustrophobic,
- Have had allergic response to contrast agents (such as iodine or gadolinium) previously,
- Have known history of severe renal insufficiency, asthma, allergic conditions, sickle cell anemia, chronic hemolytic anemia, and gastrointestinal disorders.
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2017
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT00610467
Start Date
October 1 2006
End Date
October 30 2017
Last Update
April 20 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Functional Onco-Imaging, University of California
Irvine, California, United States, 92697